Association of patient and physician characteristics with androgen-deprivation-therapy intensification in patients with de novo hormone-sensitive metastatic prostate cancer: A population-based study acsjournals.onlinelibrary.wi… Population-based study in Ontario 🇨🇦evaluated factors influencing the use of treatment intensification in older men with de novo metastatic hormone-sensitive #ProstateCancer , finding that only 24% received additional therapy beyond androgen deprivation. Physician specialty significantly impacted treatment patterns, with patients managed by radiation oncologists less likely and those seen by medical oncologists more likely to receive intensification, while older age strongly decreased the likelihood of intensified therapy. These results highlight that both patient and physician characteristics drive variation in care, emphasizing the need for targeted interventions to improve uptake of guideline-recommended, life-prolonging therapies. @DavidDan_Ngn @DrRajSat @KhattiA @AHirdMD @Soum_Roy_RadOnc @DrMichaelOng @DiMariaJiang @drgotto @GSK_UofT @RodBreau @lalaniMD @WallisCJD @OncoAlert 🚨 @Silke_Gillessen @AOmlin @nataliagandur @bavilima